Andreas Halvorsen
Viking Global Investors
Founder of Viking Global Investors, a 'Tiger Cub' fund known for long/short equity investing.
Based on the 13F filing for 2024-Q2
💼 Holdings
| Company | Value | % of Portfolio | |
|---|---|---|---|
AMAZON COM INC AMZN | $1.80T | 6.9% | Analysis → |
ADOBE INC ADBE | $1.26T | 4.9% | Analysis → |
PHILIP MORRIS INTL INC | $1.11T | 4.2% | |
MICROSOFT CORP MSFT | $1.02T | 3.9% | Analysis → |
API GROUP CORP APG | $1.02T | 3.9% | Analysis → |
US BANCORP DEL | $1.01T | 3.9% | |
APPLE INC AAPL | $966.89B | 3.7% | Analysis → |
WORKDAY INC WDAY | $885.29B | 3.4% | Analysis → |
LAS VEGAS SANDS CORP LVS | $875.52B | 3.4% | Analysis → |
PROGRESSIVE CORP | $832.26B | 3.2% | |
FORTIVE CORP FTV | $743.93B | 2.9% | Analysis → |
ROIVANT SCIENCES LTD ROIV | $730.98B | 2.8% | Analysis → |
DOLLAR TREE INC DLTR | $726.98B | 2.8% | Analysis → |
BRIDGEBIO PHARMA INC BBIO | $636.31B | 2.4% | Analysis → |
NETFLIX INC NFLX | $629.57B | 2.4% | Analysis → |
JPMORGAN CHASE & CO. JPM | $608.77B | 2.3% | Analysis → |
DOORDASH INC DASH | $602.20B | 2.3% | Analysis → |
BIOMARIN PHARMACEUTICAL INC BMRN | $581.54B | 2.2% | Analysis → |
HDFC BANK LTD HDB | $563.33B | 2.2% | Analysis → |
MCDONALDS CORP MCD | $478.08B | 1.8% | Analysis → |
BROADCOM INC AVGO | $470.58B | 1.8% | Analysis → |
T-MOBILE US INC TMUS | $439.18B | 1.7% | Analysis → |
GE VERNOVA INC GEV | $416.53B | 1.6% | Analysis → |
AMERIPRISE FINL INC | $388.32B | 1.5% | |
CAMDEN PPTY TR | $355.65B | 1.4% | |
FERGUSON PLC NEW | $324.11B | 1.2% | |
CBRE GROUP INC CBRE | $322.63B | 1.2% | Analysis → |
ROYALTY PHARMA PLC RPRX | $315.65B | 1.2% | Analysis → |
ATLASSIAN CORPORATION TEAM | $259.30B | 1.0% | Analysis → |
FREEPORT-MCMORAN INC FCX | $254.17B | 1.0% | Analysis → |
EQUITABLE HLDGS INC | $239.42B | 0.9% | |
FORD MTR CO DEL | $235.62B | 0.9% | |
UNITEDHEALTH GROUP INC UNH | $224.99B | 0.9% | Analysis → |
INTUIT INTU | $220.82B | 0.8% | Analysis → |
ACADIA HEALTHCARE COMPANY IN | $218.61B | 0.8% | |
HCA HEALTHCARE INC HCA | $210.17B | 0.8% | Analysis → |
DATADOG INC DDOG | $178.46B | 0.7% | Analysis → |
NVIDIA CORPORATION NVDA | $171.05B | 0.7% | Analysis → |
3M CO MMM | $168.02B | 0.6% | Analysis → |
CSX CORP CSX | $158.50B | 0.6% | Analysis → |
NEWAMSTERDAM PHARMA COMPANY | $154.15B | 0.6% | |
UBS GROUP AG UBS | $152.69B | 0.6% | Analysis → |
REGAL REXNORD CORPORATION RRX | $151.87B | 0.6% | Analysis → |
INTUITIVE SURGICAL INC ISRG | $150.31B | 0.6% | Analysis → |
SPOTIFY TECHNOLOGY S A | $149.04B | 0.6% | |
EPAM SYS INC | $142.26B | 0.5% | |
META PLATFORMS INC META | $134.25B | 0.5% | Analysis → |
CHARTER COMMUNICATIONS INC N | $131.12B | 0.5% | |
ELI LILLY & CO LLY | $130.53B | 0.5% | Analysis → |
INTEGER HLDGS CORP | $128.73B | 0.5% | |
SHERWIN WILLIAMS CO SHW | $121.70B | 0.5% | Analysis → |
APOLLO GLOBAL MGMT INC | $114.67B | 0.4% | |
ADAPTIVE BIOTECHNOLOGIES COR | $108.58B | 0.4% | |
SALESFORCE INC CRM | $104.16B | 0.4% | Analysis → |
STANDARD BIOTOOLS INC LAB | $103.81B | 0.4% | Analysis → |
OSCAR HEALTH INC OSCR | $93.78B | 0.4% | Analysis → |
PROCORE TECHNOLOGIES INC PCOR | $91.15B | 0.4% | Analysis → |
ALLSTATE CORP ALL | $87.04B | 0.3% | Analysis → |
MCKESSON CORP MCK | $83.03B | 0.3% | Analysis → |
FIVE9 INC FIVN | $76.49B | 0.3% | Analysis → |
NRG ENERGY INC NRG | $73.46B | 0.3% | Analysis → |
VIKING THERAPEUTICS INC VKTX | $71.80B | 0.3% | Analysis → |
CARVANA CO CVNA | $71.26B | 0.3% | Analysis → |
INSMED INC INSM | $69.41B | 0.3% | Analysis → |
PHARVARIS N V | $68.68B | 0.3% | |
4D MOLECULAR THERAPEUTICS IN | $61.60B | 0.2% | |
IMMUNOVANT INC IMVT | $61.27B | 0.2% | Analysis → |
VERTIV HOLDINGS CO VRT | $59.71B | 0.2% | Analysis → |
KKR & CO INC KKR | $57.37B | 0.2% | Analysis → |
GINKGO BIOWORKS HOLDINGS INC DNA | $47.83B | 0.2% | Analysis → |
LONGBOARD PHARMACEUTICALS IN | $44.84B | 0.2% | |
LPL FINL HLDGS INC | $36.31B | 0.1% | |
ZAI LAB LTD ZLAB | $35.31B | 0.1% | Analysis → |
DAY ONE BIOPHARMACEUTICALS I | $35.26B | 0.1% | |
ORIC PHARMACEUTICALS INC ORIC | $28.28B | 0.1% | Analysis → |
RUBRIK INC. RBRK | $27.51B | 0.1% | Analysis → |
EDGEWISE THERAPEUTICS INC EWTX | $26.68B | 0.1% | Analysis → |
INHIBRX BIOSCIENCES INC INBX | $25.33B | 0.1% | Analysis → |
PEPGEN INC PEPG | $23.66B | 0.1% | Analysis → |
SANOFI SNY | $15.83B | 0.1% | Analysis → |
TREVI THERAPEUTICS INC TRVI | $13.11B | 0.1% | Analysis → |
RALLYBIO CORP RLYB | $5.62B | 0.0% | Analysis → |
This data comes from the most recent official Form 13F filing submitted to the SEC. Some holdings may not be automatically matched to a ticker (for example, foreign securities or private funds), so a link to the analysis won't always appear. This information should not be considered investment advice.